IL127751A0 - Thrombin inhibitors - Google Patents

Thrombin inhibitors

Info

Publication number
IL127751A0
IL127751A0 IL12775197A IL12775197A IL127751A0 IL 127751 A0 IL127751 A0 IL 127751A0 IL 12775197 A IL12775197 A IL 12775197A IL 12775197 A IL12775197 A IL 12775197A IL 127751 A0 IL127751 A0 IL 127751A0
Authority
IL
Israel
Prior art keywords
thrombin inhibitors
thrombin
inhibitors
Prior art date
Application number
IL12775197A
Other languages
English (en)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL127751A0 publication Critical patent/IL127751A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
IL12775197A 1996-08-14 1997-07-29 Thrombin inhibitors IL127751A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19632773A DE19632773A1 (de) 1996-08-14 1996-08-14 Neue Thrombininhibitoren
PCT/EP1997/004104 WO1998006741A1 (de) 1996-08-14 1997-07-29 Thrombininhibitoren

Publications (1)

Publication Number Publication Date
IL127751A0 true IL127751A0 (en) 1999-10-28

Family

ID=7802624

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12775197A IL127751A0 (en) 1996-08-14 1997-07-29 Thrombin inhibitors

Country Status (30)

Country Link
US (1) US6114358A (pl)
EP (1) EP0956294B1 (pl)
JP (1) JP4089981B2 (pl)
KR (1) KR20000030002A (pl)
CN (1) CN1228783A (pl)
AR (1) AR009070A1 (pl)
AT (1) ATE268781T1 (pl)
AU (1) AU735364B2 (pl)
BG (1) BG103096A (pl)
BR (1) BR9711191A (pl)
CA (1) CA2263220A1 (pl)
CO (1) CO4900030A1 (pl)
CZ (1) CZ299634B6 (pl)
DE (2) DE19632773A1 (pl)
DK (1) DK0956294T3 (pl)
ES (1) ES2221062T3 (pl)
HR (1) HRP970441B1 (pl)
HU (1) HUP0001826A3 (pl)
ID (1) ID17873A (pl)
IL (1) IL127751A0 (pl)
MY (1) MY132820A (pl)
NO (1) NO990662L (pl)
NZ (1) NZ333679A (pl)
PL (1) PL188411B1 (pl)
PT (1) PT956294E (pl)
RU (1) RU2175328C2 (pl)
SK (1) SK284915B6 (pl)
TR (1) TR199900310T2 (pl)
WO (1) WO1998006741A1 (pl)
ZA (1) ZA977239B (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9602263D0 (sv) 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
DE19632773A1 (de) * 1996-08-14 1998-02-19 Basf Ag Neue Thrombininhibitoren
DE19632772A1 (de) 1996-08-14 1998-02-19 Basf Ag Neue Benzamidine
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
SE9704543D0 (sv) 1997-12-05 1997-12-05 Astra Ab New compounds
EP1049673A1 (de) * 1998-01-26 2000-11-08 Basf Aktiengesellschaft Heterocyclische amidine als kallikrein protease inhibitoren
HUP0100082A3 (en) * 1998-01-26 2001-12-28 Abbott Gmbh & Co Kg Thrombin inhibitor, peptide derivatives, pharmaceutical compositions comprising thereof and their use
NZ506507A (en) * 1998-02-09 2003-08-29 Dimensional Pharm Inc Heteroaryl amidine, methylamidine or guanidine derivatives useful as urokinase inhibitors
NZ513701A (en) * 1999-02-09 2001-09-28 Dimensional Pharm Inc Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
IL145771A0 (en) * 1999-04-09 2002-07-25 Basf Ag Low-molecular inhibitors of complement proteases
CA2370267A1 (en) 1999-04-09 2000-10-19 Basf Aktiengesellschaft Prodrugs of thrombin inhibitors
JP2002541252A (ja) * 1999-04-09 2002-12-03 ビーエーエスエフ アクチェンゲゼルシャフト アミジンの製造
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
KR20010002891A (ko) * 1999-06-18 2001-01-15 성재갑 아릴 또는 헤테로아릴 그룹을 갖는 트롬빈 억제제 및 그 제조 방법
DE19933861A1 (de) * 1999-07-23 2001-01-25 Basf Ag Verfahren zur Herstellung von 2-Aminomethyl-4-cyano-thiazol
DE10049937A1 (de) * 2000-10-06 2002-04-11 Knoll Ag Niedermolekulare Inhibitoren von Serinproteasen mit Polyhydroxyalkyl- und Polyhydroxycycloalkylresten
DE10064797A1 (de) * 2000-12-22 2002-06-27 Knoll Ag Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon
FI122575B (fi) 2006-12-04 2012-03-30 Dieffenbacher Panelboard Oy Laitteisto kuitujen, kuten lastujen sirottelemiseksi
JP6155187B2 (ja) 2010-03-30 2017-06-28 ヴァーセオン コーポレイション トロンビンの阻害剤としての多置換芳香族化合物
WO2014145986A1 (en) 2013-03-15 2014-09-18 Verseon, Inc. Multisubstituted aromatic compounds as serine protease inhibitors
ES2791749T3 (es) 2013-03-15 2020-11-05 Verseon Corp Halogenopirazoles como inhibidores de la trombina
CN103520160B (zh) * 2013-10-17 2015-04-22 广东药学院 三棱中肽类化合物的应用
KR20170048410A (ko) 2014-09-17 2017-05-08 베르선 코포레이션 세린 프로테아제 저해제로서의 피라졸릴-치환된 피리돈 화합물
AU2016224974B2 (en) 2015-02-27 2019-09-26 Verseon Corporation Substituted pyrazole compounds as serine protease inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US5332726A (en) * 1989-09-29 1994-07-26 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic peptides and pseudopeptides
GB9007751D0 (en) * 1990-04-05 1990-06-06 Ciba Geigy Ag Novel platelet-aggregation inhibitors
EP0503203A1 (en) * 1991-03-15 1992-09-16 Merrell Dow Pharmaceuticals Inc. Novel thrombin inhibitors
AU675981B2 (en) * 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
EP0648780A1 (en) * 1993-08-26 1995-04-19 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
ZA951617B (en) * 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.
DE4421052A1 (de) * 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
DE4443390A1 (de) * 1994-12-06 1996-06-13 Basf Ag Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
KR100388185B1 (ko) * 1995-02-17 2003-11-28 애보트 게엠베하 운트 콤파니 카게 트롬빈 억제제로서의 신규 디펩티드 아미딘
DE19632772A1 (de) * 1996-08-14 1998-02-19 Basf Ag Neue Benzamidine
DE19632773A1 (de) * 1996-08-14 1998-02-19 Basf Ag Neue Thrombininhibitoren

Also Published As

Publication number Publication date
DE19632773A1 (de) 1998-02-19
AU735364B2 (en) 2001-07-05
CA2263220A1 (en) 1998-02-19
HUP0001826A3 (en) 2002-01-28
SK284915B6 (sk) 2006-02-02
CO4900030A1 (es) 2000-03-27
HRP970441B1 (en) 2005-04-30
CZ299634B6 (cs) 2008-10-01
PL331540A1 (en) 1999-07-19
PT956294E (pt) 2004-10-29
JP4089981B2 (ja) 2008-05-28
DE59711714D1 (de) 2004-07-15
BG103096A (en) 1999-09-30
WO1998006741A1 (de) 1998-02-19
TR199900310T2 (xx) 1999-04-21
HUP0001826A2 (hu) 2000-09-28
ES2221062T3 (es) 2004-12-16
NO990662D0 (no) 1999-02-12
CZ48699A3 (cs) 1999-05-12
JP2000516598A (ja) 2000-12-12
BR9711191A (pt) 1999-08-17
NO990662L (no) 1999-02-12
KR20000030002A (ko) 2000-05-25
AR009070A1 (es) 2000-03-08
AU3941797A (en) 1998-03-06
PL188411B1 (pl) 2005-01-31
ATE268781T1 (de) 2004-06-15
NZ333679A (en) 1999-09-29
RU2175328C2 (ru) 2001-10-27
ZA977239B (en) 1999-02-15
HRP970441A2 (en) 1998-06-30
EP0956294A1 (de) 1999-11-17
DK0956294T3 (da) 2004-10-11
US6114358A (en) 2000-09-05
SK899A3 (en) 1999-06-11
MY132820A (en) 2007-10-31
EP0956294B1 (de) 2004-06-09
CN1228783A (zh) 1999-09-15
ID17873A (id) 1998-02-05

Similar Documents

Publication Publication Date Title
HRP960075B1 (en) New thrombin inhibitors
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
AU3832895A (en) Thrombin inhibitors
HUP0001826A3 (en) Thrombin inhibitors
PL328307A1 (en) Serinic protease inhibitors
PL331803A1 (en) Bidonoric metaloprotease inhibitors
PL328875A1 (en) Serinic protease inhibitors
PL328223A1 (en) Aspartil protease inhibitors
IL136139A0 (en) Thrombin inhibitors
AU3396697A (en) Thrombin inhibitor
GB9613718D0 (en) Thrombin inhibitors
IL117437A0 (en) Novel thrombin inhibitors
IL121474A0 (en) Thrombin inhibitors
GB9624817D0 (en) Metalloproteinase inhibitors
ZA974779B (en) Thrombin inhibitors.
EP1027333A4 (en) THROMBIN INHIBITORS
GB9625311D0 (en) Thrombin inhibitors
GB9624319D0 (en) Thrombin inhibitors
GB9624278D0 (en) Thrombin inhibitors
GB9605163D0 (en) Thrombin inhibitors
GB9624292D0 (en) Thrombin inhibitors
SI0956294T1 (en) Thrombin inhibitors
GB9704209D0 (en) Thrombin inhibitors
GB9716872D0 (en) Thrombin Inhibitors
ZA968922B (en) Thrombin inhibitors

Legal Events

Date Code Title Description
HP Change in proprietorship